跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 79,278 条关于
“Brain Bispecific T cell Engager”
全部
79,278
临床试验
56,566
药物
6,420
机构
294
资讯
15,998
8个月前
Adaptin Bio Receives First IRB Approval for Novel Brain Cancer Immunotherapy APTN-101 Phase 1 Trial
2年前
FDA Clears Investigational New Drug Application for Adaptin Bio's Glioblastoma Therapy APTN-101
上个月
Adaptin Bio Opens Enrollment in Phase 1 Trial of APTN-101 for EGFRvIII-Positive Glioblastoma
去年
Cullinan Therapeutics Licenses BCMA-Targeted Bispecific T Cell Engager for Autoimmune Disease Development
6个月前
Context Therapeutics Advances T-Cell Engager Pipeline with Three Bispecific Antibodies in Clinical Development
去年
Otsuka Pharmaceutical Secures Global Rights to HBM7020 BCMAxCD3 Bispecific T-Cell Engager for Autoimmune Diseases
3个月前
Author Correction Issued for MAGE-A4/MAGE-A8-Targeted TCR-Based Bispecific T Cell Engager Study
去年
Merck & Co. Acquires Curon Bio's Bispecific T-Cell Engager for $1.3 Billion
7个月前
Florida Cancer Specialists Launches Phase 3 Trial of Pasritamig Bispecific T-Cell Engager for Castration-Resistant Prostate Cancer
8个月前
First U.S. Patient Receives Alveltamig, Novel Trispecific T-Cell Engager for Small Cell Lung Cancer
第 1 页，共 1600 页
上一页
下一页
